Navigation Links
Westaim terminates reorganization agreement and cancels shareholders' meeting

CALGARY, Nov. 4 /PRNewswire-FirstCall/ - The Westaim Corporation announced today that its reorganization agreement with several western Canadian construction services companies has been terminated.

Under the terms of the proposed reorganization agreement dated on October 3, 2008, subscription agreements for a private placement of common shares for gross proceeds of $15 million were required to be signed and delivered within 14 days of the mailing of the information circular for Westaim's special meeting of shareholders. Due to the current volatile state of the financial markets and the general state of the investment climate, sufficient subscribers for the private placement could not be found.

As a consequence of terminating the reorganization agreement, Westaim has cancelled the shareholders' meeting called for November 21, 2008.

"Westaim will continue its review of strategic alternatives in light of this development," said Drew Fitch, President & CEO, The Westaim Corporation. "The board of directors will examine all possible options for the longer-term structure of the company moving forward and remain committed to realizing maximum value for shareholders."

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Westaim to deregister its common stock in the United States
2. Westaim announces sale of iFire Technology Ltd. assets
3. Westaim announces 2008 second quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
5. Westaim announces 2008 first quarter results
6. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
7. Westaim announces 2007 year-end results
8. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
9. Westaim reduces ABCP exposure
10. Westaim announces 2007 third quarter results
11. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... D.C. (PRWEB) , ... June 24, 2016 , ... ... Heroes Golf Classic Tournament held on June 20th at the Woodmont Country Club ... charity, Luke’s Wings, an organization dedicated to helping service members that have been wounded ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: